Investor Webcast – WELTRUZA™ FDA Approval
October 13, 2026
General Meeting 2026 (French)
October 13, 2026
Videoconference • Annual results 2025-26
September 24, 2026
Videoconference • Annual results 2025-26
June 16, 2026
R&D Day – From Science to Long-Term Value Creation
May 12, 2026
